Scarica l'app Stockscreener
324.79
0.16%
0.94
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$323.85
Aprire:
$321.91
Volume 24 ore:
1.06M
Relative Volume:
0.39
Capitalizzazione di mercato:
$175.28B
Reddito:
$37.30B
Utile/perdita netta:
$7.80B
Rapporto P/E:
22.59
EPS:
14.3793
Flusso di cassa netto:
$8.60B
1 W Prestazione:
-4.47%
1M Prestazione:
-6.77%
6M Prestazione:
+1.41%
1 anno Prestazione:
+15.83%
Intervallo 1D:
$320.52
$324.88
Intervallo di 1 settimana:
$320.52
$349.54
Portata 52W:
$261.43
$391.29
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, AZN, MRK
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
324.60 | 174.88B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
983.63 | 863.14B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
225.91 | 539.70B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
206.71 | 368.19B | 62.82B | 3.62B | 17.82B | 2.0331 |
AZN
Astrazeneca Plc
|
181.33 | 284.52B | 60.48B | 10.40B | 8.05B | 3.3297 |
MRK
Merck Co Inc
|
113.27 | 279.37B | 65.59B | 8.93B | 12.36B | 3.5532 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-21 | Iniziato | Canaccord Genuity | Hold |
| 2026-03-10 | Iniziato | Jefferies | Hold |
| 2026-02-20 | Iniziato | Barclays | Equal Weight |
| 2026-01-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Ripresa | UBS | Buy |
| 2025-12-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2025-11-24 | Ripresa | Truist | Hold |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-09-03 | Ripresa | Raymond James | Mkt Perform |
| 2025-05-20 | Ripresa | Guggenheim | Neutral |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
What’s at stake in Amgen’s showdown with the FDA? - Pharma Voice
Amgen Beat Q1 2026 Earnings and the Stock Fell 5%. Here’s What Investors Are Missing - TIKR.com
Erste Group cuts Amgen stock rating on slowing sales growth By Investing.com - Investing.com Canada
QRG Capital Management Inc. Increases Stake in Amgen Inc. $AMGN - MarketBeat
Intact Investment Management Inc. Decreases Position in Amgen Inc. $AMGN - MarketBeat
Amgen adds $300m to Puerto Rico manufacturing push - The Pharma Letter
Christine Messmer PC Invests $1.20 Million in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Expands Manufacturing with Additional $300M Investm - GuruFocus
Standing Bone Strong: Introducing a New Awareness Symbol for Osteoporosis - Amgen
[144] AMGEN INC SEC Filing - Stock Titan
Amgen to invest additional $300 million to boost US manufacturing footprint - Reuters
Pfizer vs. Amgen: Which Big Pharma Stock Is the Better Value Right Now? - TIKR.com
Amgen (AMGN) Invests $300M to Boost U.S. Manufacturing Capacity - GuruFocus
Amgen invests $300M more in Puerto Rico biologics plant - Yahoo Finance
Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge? - Yahoo Finance
Amgen (AMGN) Stock Invests $300M to Expand Puerto Rico Manufacturing - CoinCentral
Amgen to Invest $300 Million in Expanding Puerto Rico Biologics Plant - marketscreener.com
AMGN Maintained by Guggenheim -- Price Target Lowered to $340 - GuruFocus
Amgen Expands Puerto Rico Biologics Facility With Additional $300M Investment Amid Tariff Pressure - Quiver Quantitative
Amgen stock slips despite $300M Puerto Rico plant expansion By Investing.com - Investing.com South Africa
Amgen stock slips despite $300M Puerto Rico plant expansion - Investing.com
Amgen to invest additional $300 million to boost US manufacturing footprint By Reuters - Investing.com
Guggenheim Lowers Amgen (NASDAQ:AMGN) Price Target to $340.00 - MarketBeat
Amgen to invest $300 million in Puerto Rico manufacturing facility By Investing.com - Investing.com
Amgen announces additional $300 million U.S. manufacturing investment, totaling nearly $2 billion over the last year - marketscreener.com
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion - Fierce Pharma
Guggenheim cuts Amgen stock price target to $340 on valuation By Investing.com - Investing.com Canada
Guggenheim cuts Amgen stock price target to $340 on valuation - Investing.com
Baron Health Care Fund’s Performance Impacted by Amgen (AMGN) Omission - Insider Monkey
Truist Financial Corp Sells 37,080 Shares of Amgen Inc. $AMGN - MarketBeat
Peregrine Asset Advisers Inc. Purchases 13,173 Shares of Amgen Inc. $AMGN - MarketBeat
Gouws Capital LLC Lowers Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Sees C-Suite Shifts - Los Angeles Business Journal
Amgen Inc. $AMGN Shares Purchased by Ascent Wealth Partners LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by PKO Investment Management Joint Stock Co - MarketBeat
Hussman Strategic Advisors Inc. Acquires Shares of 8,400 Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Horizon Investments LLC - MarketBeat
Did Amgen’s Raised 2026 Outlook and AI-Focused Overhaul Just Shift AMGN’s Investment Narrative? - simplywall.st
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S Trade Ideas — FWB:AMG0 - TradingView
MSN Money - MSN
Amgen Q1 2026: Revenue Grows 6% as Six Key Drivers Outpace Patent Losses - TIKR.com
Research Alert: CFRA Keeps Buy Rating On Shares Of Amgen Inc. - Moomoo
Amgen Inc. $AMGN Shares Sold by Strs Ohio - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Immunome (IMNM) and Resmed (RMD) - The Globe and Mail
PFA Pension Forsikringsaktieselskab Purchases Shares of 342,594 Amgen Inc. $AMGN - MarketBeat
Robertson Stephens Wealth Management LLC Grows Stake in Amgen Inc. $AMGN - MarketBeat
Jennison Associates LLC Sells 91,343 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc (AMGN) Shares Fall 4.8% -- What GF Score of 93 Tells I - GuruFocus
Amgen (AMGN) Margin Expansion In Q1 2026 Tests Cautious Growth Narratives - simplywall.st
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Icon (ICLR) - The Globe and Mail
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Amgen Inc Azioni (AMGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bradway Robert A | Chairman, CEO and President |
Mar 04 '26 |
Option Exercise |
156.35 |
119,782 |
18,727,916 |
576,928 |
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Option Exercise |
169.19 |
54,792 |
9,270,143 |
107,119 |
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Sale |
379.12 |
54,792 |
20,772,595 |
76,618 |
0.18%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):